BACKGROUND: Whether changes in blood pressure (BP) over women's midlife are more driven by chronological aging or the menopause transition has been debated. We sought to determine whether women can be classified into distinct trajectory groups based on pattern and level of systolic BP (SBP), diastolic BP, pulse pressure (PP), and mean arterial pressure (MAP) over the menopause transition, and to assess whether menopause-related factors predict the group and level of BP measures. METHODS: Participants were from the SWAN (Study of Women's Health Across the Nation). Group-based trajectory modeling was used to identify women who shared distinct BP trajectories over time relative to menopause onset and to assess associations of menopause-related factors with trajectory group and level of BP measures. An accelerated rise relative to menopause onset suggests a menopause contribution. RESULTS: The study included 3302 multiracial and multiethnic women with BP measures over 17 follow-up visits (baseline age [SD]: 46.3 [2.7]). Women were classified into either low, medium, or high trajectory group in each BP measure. The low SBP, PP, and MAP trajectories (in 35%, 53%, and 28% of the cohort, respectively) were rising slowly before menopause but showed a significant accelerated rise 1 year after menopause, indicating a menopause contribution. The remaining BP trajectories were rising up until menopause and either continued with the same rise or declined after menopause. A younger menopause age predicted the low SBP, PP, and MAP trajectories. A greater follicle-stimulating hormone level predicted lower SBP and PP levels, while vasomotor symptoms occurrence predicted higher SBP, PP, and MAP levels over time. Estradiol did not predict trajectory or level of any BP measure. CONCLUSIONS: Distinct BP trajectories over the menopause transition exist that revealed a group of women whose SBP, PP, and MAP trajectories are consistent with a menopause contribution. Our findings support frequent monitoring of BP during the menopause transition.
BACKGROUND: Whether changes in blood pressure (BP) over women's midlife are more driven by chronological aging or the menopause transition has been debated. We sought to determine whether women can be classified into distinct trajectory groups based on pattern and level of systolic BP (SBP), diastolic BP, pulse pressure (PP), and mean arterial pressure (MAP) over the menopause transition, and to assess whether menopause-related factors predict the group and level of BP measures. METHODS: Participants were from the SWAN (Study of Women's Health Across the Nation). Group-based trajectory modeling was used to identify women who shared distinct BP trajectories over time relative to menopause onset and to assess associations of menopause-related factors with trajectory group and level of BP measures. An accelerated rise relative to menopause onset suggests a menopause contribution. RESULTS: The study included 3302 multiracial and multiethnic women with BP measures over 17 follow-up visits (baseline age [SD]: 46.3 [2.7]). Women were classified into either low, medium, or high trajectory group in each BP measure. The low SBP, PP, and MAP trajectories (in 35%, 53%, and 28% of the cohort, respectively) were rising slowly before menopause but showed a significant accelerated rise 1 year after menopause, indicating a menopause contribution. The remaining BP trajectories were rising up until menopause and either continued with the same rise or declined after menopause. A younger menopause age predicted the low SBP, PP, and MAP trajectories. A greater follicle-stimulating hormone level predicted lower SBP and PP levels, while vasomotor symptoms occurrence predicted higher SBP, PP, and MAP levels over time. Estradiol did not predict trajectory or level of any BP measure. CONCLUSIONS: Distinct BP trajectories over the menopause transition exist that revealed a group of women whose SBP, PP, and MAP trajectories are consistent with a menopause contribution. Our findings support frequent monitoring of BP during the menopause transition.
Authors: Haywood L Brown; John J Warner; Eugenia Gianos; Martha Gulati; Alexandria J Hill; Lisa M Hollier; Stacey E Rosen; Mary L Rosser; Nanette K Wenger Journal: Circulation Date: 2018-05-10 Impact factor: 29.690
Authors: Saad Samargandy; Karen A Matthews; Maria M Brooks; Emma Barinas-Mitchell; Jared W Magnani; Imke Janssen; Steven M Hollenberg; Samar R El Khoudary Journal: Arterioscler Thromb Vasc Biol Date: 2020-01-23 Impact factor: 8.311
Authors: Samar R El Khoudary; Brooke Aggarwal; Theresa M Beckie; Howard N Hodis; Amber E Johnson; Robert D Langer; Marian C Limacher; JoAnn E Manson; Marcia L Stefanick; Matthew A Allison Journal: Circulation Date: 2020-11-30 Impact factor: 29.690
Authors: A C de Kat; V Dam; N C Onland-Moret; M J C Eijkemans; F J M Broekmans; Y T van der Schouw Journal: BMC Med Date: 2017-01-04 Impact factor: 8.775
Authors: João Delgado; Kirsty Bowman; Alessandro Ble; Jane Masoli; Yang Han; William Henley; Scott Welsh; George A Kuchel; Luigi Ferrucci; David Melzer Journal: JAMA Intern Med Date: 2018-01-01 Impact factor: 21.873
Authors: Hongwei Ji; Andy Kim; Joseph E Ebinger; Teemu J Niiranen; Brian L Claggett; C Noel Bairey Merz; Susan Cheng Journal: JAMA Cardiol Date: 2020-03-01 Impact factor: 30.154
Authors: Cindy Z Kalenga; Jacqueline L Hay; Kevin F Boreskie; Todd A Duhamel; Jennifer M MacRae; Amy Metcalfe; Kara A Nerenberg; Magali Robert; Sofia B Ahmed Journal: Front Cardiovasc Med Date: 2022-06-10